The FDA advisory panel unanimously supported mRNA-1010/mFLUSIVA for adults 50–64 and 65+, and the stock is already reacting ...

Buy iShares 7-10 Year Treasury ETF (IEF) or, more directly, iShares 0-3 Month Treasury (SGOV) is too short; use IEF to ...

The new buyback + selective Bitcoin sales framework is designed to “buy time” until Bitcoin stabilizes, while strengthening ...

The key datapoint is redemption requests easing ($4.7B vs $5.4B) and OCIC/OTIC tender pressure drifting down (OCIC 21.9%→18.8 ...

The stock sold off with the whole semis, but HSBC just lifted its server-CPU growth view (2026/27) and put a $200 target on ...

The news frames Meta Compute as a direct threat to GPU rental economics, but that also means Meta is monetizing its AI ...

The news is a distraction (Trump praise + $250M “Trump Accounts” headline) while the real driver is the market’s rotation out ...

Shares of Nvidia fell about 1% in early trading after finishing Wednesday below the $200 level, a level it has struggled to ...

The thesis is that HOOD can become a global “hyperscaler” brokerage by exporting its mobile-first platform into Europe/Asia ...

Q2 deliveries beat (12,194 vs ~11,000) and management immediately raised 2026 guidance to at least 65,000 from 62,000—this is ...

Deliveries beat hard (480k vs ~406–409k expected) and China/Shanghai momentum is accelerating (June Model 3/Y +24% YoY; Q2 ...

The weak jobs print pushed yields down and cut the odds of another Fed hike this year (75.6% vs ~84%). If the Fed delays ...